Medical devices, healthcare technology and the business of care
510(k) clearance · K263154

CarboClear Cervical Navigated Instruments

CarboFix Orhtopedics , Ltd. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK263154

What did the FDA decide?

CarboClear® Cervical Navigated Instruments, submitted by CarboFix Orhtopedics , Ltd., received a substantially equivalent (SESE) decision from the FDA in the 510(k) program, as recorded with decision date 2026-10-09 under document record K263154. The source lists the device specialty as Neurology and product code OLO. A substantially equivalent decision indicates 510(k) clearance rather than premarket approval; it does not establish safety or effectiveness through the PMA pathway.

The available record is a decision listing only. It does not identify the predicate device, the specific components or changed items, the indications for use, or any performance data supporting the submission. The applicant name appears as spelled in the source. Readers needing the cleared scope, labeling, or comparison to a predicate should consult the underlying FDA 510(k) document rather than this summary.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263154
Regulatory pathway
510(k) premarket notification
Product code
OLO
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthopedic Stereotaxic Instrument.

Product code
OLO
FDA device class
2

FDA decision timeline

  1. K263154 received

    Application receipt date recorded by FDA.

  2. K263154 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OLO

Product / regulatory recordCompanyPathwayDecision dateSource
GPS AnkleK262567
Blue Ortho510(k) clearanceOct 26, 2026FDA
7D Surgical ULC510(k) clearanceOct 19, 2026FDA
THINK Surgical, Inc.510(k) clearanceOct 16, 2026FDA
Brainlab SE510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

CarboFix Orhtopedics , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Herzeliya

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records